RBC Capital Remains a Hold on Apellis Pharmaceuticals (APLS)
In a report released yesterday, Lisa Walter from RBC Capital maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), with ...
The Australian Financial Review7d
ASX misses record high; Citi, UBS forecast Feb rate cut; Star up 13pc
Chief economist Luci Ellis said Wednesday’s lower than ... I will address that question in coming weeks.” RBC Capital Markets believes there is enough in Wednesday’s inflation for the ...
Investing26d
Apellis stock drops on Astellas drug update
RBC (TSX:RY) Capital Markets echoed this sentiment, suggesting that the anticipated dosing regimen advantage for Syfovre on its label may no longer be a sustainable competitive edge. Lisa Walter from ...
Investing29d
Apellis stock target lifted, keeps Sector Perform on approved drugs
On Tuesday, RBC (TSX:RY) Capital Markets adjusted its stock price target for Apellis Pharmaceuticals (NASDAQ:APLS), increasing it to $26.00 from the previous $24.00, while maintaining a Sector Perform ...
Investing7d
RBC Capital Markets upgrades EssilorLuxottica citing growth potential
Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the ...
Investing5d
RBC Capital Markets raises LVMH price target to €780 on stronger revenue outlook
Investing.com -- RBC Capital Markets in a note dated Friday raised its price target for LVMH Moët Hennessy Louis Vuitton to €780 from €700 following the Luxury goods company’s fourth ...
The Australian Financial Review5d
Barrenjoey poaches managing director from RBC Capital Markets
RBC Capital Markets came in at No. 5 on Dealogic’s 2024 M&A league tables (volume by adviser) while Barrenjoey ranked seventh. Big equity raises in the digital infrastructure sector were a major ...